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Abstract
Background: Multicentre drug use evaluations are described in the literature infrequently and usually publish
only the results. The purpose of this paper is to describe the experience of Queensland hospitals participating in
the Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION) project, specifically
evaluating the implementation of this project, detailing benefits and drawbacks of involvement in a national drug
use evaluation program.
Methods: Emergency departments from nine hospitals in Queensland, Australia, participated in CAPTION, a
national quality improvement project, conducted in 37 Australian hospitals. CAPTION was aimed at optimising
prescribing in the management of Community-Acquired Pneumonia according to the recommendations of the
Australian Therapeutic Guidelines: Antibiotic 12th edition. The project involved data collection, and evaluation,
feedback of results and a suite of targeted educational interventions including audit and feedback, group
presentations and academic detailing.
A baseline audit and two drug use evaluation cycles were conducted during the 2-year project. The
implementation of the project was evaluated using feedback forms after each phase of the project (audit or
intervention). At completion a group meeting with the hospital coordinators identified positive and negative
elements of the project.
Results: Evaluation by hospitals of their participation in CAPTION demonstrated both benefits and drawbacks.
The benefits were grouped into the impact on the hospital dynamic such as; improved interdisciplinary working
relationships (e.g. between pharmacist and doctor), recognition of the educational/academic role of the
pharmacist, creation of ED Pharmacist positions and enhanced involvement with the National Prescribing Service,
and personal benefits. Personal benefits included academic detailing training for participants, improved
communication skills and opportunities to present at conferences. The principal drawback of participation was
the extra burden on already busy staff members.
Conclusion: A national multicentre drug use evaluation project such as CAPTION allows hospitals which would
otherwise not undertake such projects the opportunity to participate. The Queensland arm of CAPTION
demonstrated benefits to both the individual participants and their hospitals, highlighting the additional value of
participating in a multicentre project of this type.
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Background
Few true multicentre Drug Use Evaluations (DUEs) are
described in the literature [1]. The CAPTION (Commu-
nity-Acquired Pneumonia (CAP) Towards Improving
Outcomes Nationally) project was designed as a national
quality improvement project, with concurrent drug use
evaluations of the management of CAP in the Emergency
Department (ED) being conducted in 37 hospitals across
Australia [2]. The project was supported and funded by
the National Prescribing Service (NPS) Ltd, an independ-
ent, non-profit member-based organisation providing
accurate, balanced, evidence-based information and serv-
ices to health professionals and the community on Qual-
ity Use of Medicines (QUM)[3]. The NPS, established in
1997, is funded by the Australian Government Depart-
ment of Health and Ageing.
Some larger hospitals in Australia provide a drug use eval-
uation program, run mainly by pharmacists or clinical
pharmacologists (where available); however these pro-
grams essentially run independently at an individual hos-
pital level. Until recent years, the NPS focused on
community prescribing issues, but it is recognised that
prescribing may be initiated in hospital and continued in
the community. The NPS identified national DUEs as a
means to influence in-hospital drug use, and subse-
quently prescribing in the community. The NPS also
sought to introduce some of the educational skills cur-
rently used in the community such as educational visiting
(academic detailing) techniques and skills to a broader
audience.
Despite the availability of Australian guidelines [4],
knowledge of and adherence to the Community Acquired
Pneumonia (CAP) management guidelines from the Aus-
tralian Therapeutic Guidelines – Antibiotics (TGAB) in
Australian hospitals is not optimal[5,6] Australia is fortu-
nate to have the Therapeutic Guidelines, an independent
organisation dedicated to developing guidelines for ther-
apy from the latest world literature, interpreted and dis-
tilled by Australia's most eminent and respected experts
[4]. The Therapeutic Guidelines – Antibiotics were first
published in 1978, and are now available in the 13th edi-
tion, in both hard copy and electronically [7]. The diffi-
culty arises, as with many guidelines, in getting the best
evidence actually translated into clinical practice.
The TGAB recommend treatment of CAP according to
severity, as assessed by the Pneumonia Severity Index
(PSI), a scoring system that was developed and validated
by a large number of North American studies [8,9]. The
TGAB includes a management algorithm, using the PSI
severity class, to determine the most appropriate antibi-
otic choice and the most suitable site for management i.e.
at home, at a general ward level or an intensive care unit
[7,8].
The TGAB-recommended antibiotics were based on cur-
rent microbiological trends in Australia. Streptococcus
pneumonia is the most common cause of CAP in Aus-
tralia [7] and although about 20% of clinical isolates have
reduced susceptibility to penicillin, it is rare in Australia
that the penicillin minimum inhibitory concentration
exceeds 4 mg/L [10]. This differs to a number of other
countries where resistance to penicillin is higher [11].
This manuscript provides details about the CAPTION
experience in one state, QLD, specifically evaluating the
implementation of the CAPTION project in QLD hospi-
tals, detailing any benefits and drawbacks of involvement
in a national drug use evaluation program.
Methods
In 2004 Queensland (QLD) hospitals, public or private,
with an Emergency Department, were deemed eligible
and were invited to participate. Nine hospitals in QLD
agreed. Approval from the Institutional Human Research
Ethics Committees was sought where necessary, with
some Committees requesting full ethical review.
The project employed established drug use evaluation
(DUE) methodology, [12,13] previously successfully
implemented across a number of other hospital projects
by the QLD DUE group, NSW Therapeutic Advisory
Group and the Victorian DUE Group previously. The
CAPTION project involved data collection, and evalua-
tion using the TGAB (12th Ed) as the benchmark, feedback
of evaluated data and targeted educational interventions.
A baseline audit followed by two complete DUE cycles
were implemented during the course of the 2-year project
[12,13].
Each cycle involved the collection of data on 20 consecu-
tive patients who presented to the ED with a provisional
diagnosis of community-acquired pneumonia and were
prescribed antibiotics while in the ED. Inclusion criteria
were that the patient must be at least 18 years of age, and
have a diagnosis of CAP documented in the medical
record by ED doctors. It was assumed that the choice of
empirical antibiotics was based on this diagnosis, and it
was not judged whether the initial diagnosis was in fact
correct.
Patients were excluded if they were less than 18 years of
age; immunosuppressed; had cystic fibrosis; bronchiecta-
sis; tuberculosis; aspiration or hospital acquired pneumo-
nia; or had been discharged from hospital in the previous
14 days or transferred from another hospital.BMC Pulmonary Medicine 2009, 9:38 http://www.biomedcentral.com/1471-2466/9/38
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This baseline data collection was followed by the imple-
mentation of a suite of interventions including academic
detailing; provision of wall posters and PSI cards (to be
attached to the identification (ID) badge) and group feed-
back presentations on results of the audit. This was fol-
lowed by another period of data collection (audit two)
and a second intervention and a final (third) audit.
Academic detailing training was provided to at least one
person in each hospital. This person was nominated by
the hospital, to provide the one-on-one education in that
hospital. Training consisted of attendance at a two-day
workshop, prior to the implementation of education,
where the principles of social marketing were explained,
and the opportunity provided to partake in role plays
using these skills, with medical personnel from local
emergency departments.
As each hospital completed data collection, the data (de-
identified for patients) were sent to the QLD Project Coor-
dinator and analysis conducted (de-identified for hospi-
tal). The proportion of patients for whom a PSI
calculation had been recorded and the proportion of
patients whose treatment was in concordance with the
TGAB were determined using the Auditmaker® program,
programmed with the TGAB CAP management algorithm.
The implementation of the project was evaluated using
feedback forms (Additional files 1 and 2) after each phase
of the project (audit or intervention). Information col-
lected included: duration of data collection period,
number of records reviewed, ease of collection, time
taken, and number of people educated, educational tools
used and problems encountered during the education.
Data was summarised by the state coordinator looking for
themes. At the completion of the project a group meeting
was held with the hospital coordinators during which
positive and negative elements of the project were identi-
fied by individual hospitals using a presentation template,
and general discussion of other benefits or drawbacks
held.
The CAPTION project as a whole aimed to:
￿ Evaluate current practice with regards to management of
CAP in Emergency Departments
￿ Introduce and implement the CAP management guide-
lines (TGAB 12th Ed) into the emergency department
￿ Influence and improve the prescribing practice in the
management of CAP in the emergency department
￿ Train hospital health care professionals in appropriate
techniques for influencing and improving prescribing
practice
Results
Data collection evaluation
Evaluation logs of data collection were completed by all
hospitals after the first two audit cycles. In both audit
cycles data were predominantly collected by pharmacists
(11 occasions) but also included pharmacy students (6),
medical staff (3) and students (1), registered nurse (3)
and a pre-registration pharmacist (1). In both cycles some
hospitals had multiple people involved in data collection,
which may have resulted in some inconsistencies. Each
hospital was provided with a manual which outlined spe-
cific details with regards to data collection, and regular
contact was made by the state coordinator via email and
teleconferences to answer any questions. All submitted
data were checked by the state coordinator for anomalies
and corrected before analysis. Problems encountered were
similar across all sites and both audits and included:
￿ Access to records
￿ Legibility of Dr's writing
￿ Inadequate information recorded in the chart
Time required collecting the data varied, with the average
time to review a record & collect data was initially 28 min-
utes. This decreased in the second audit to 15 minutes, as
data collectors became familiar with the medical record
and the requirement of data collection.
Intervention Evaluation
Sixteen of eighteen possible evaluation logs were returned
after the completion of the two intervention cycles. These
logs indicated that implementation of the academic
detailing intervention was difficult at a number of sites,
with at least two sites being unable to implement aca-
demic detailing at various times due to time constraints
and staffing levels. Where detailing occurred it was how-
ever found that most doctors were really appreciative of
someone taking the time to talk to them. This was espe-
cially relevant in the ED where visits by pharmaceutical
representatives may be less frequent, and not involve jun-
ior staff. The detailers found that the detailing cards (avail-
able upon request from authors) were very useful, as a
guide to lead them through the interaction as well as keep-
ing the message consistent; however the detailers did find
that not all staff wanted to keep them.
The barrier to the implementation of academic detailing
in the Emergency Department most commonly identified
was time. Time was an issue for the person conducting the
educational visits. It was difficult to make an appointment
with Emergency Department doctors. Another concern
was the lack of available appropriate space to conduct a
one-on-one educational visit in a busy Emergency Depart-BMC Pulmonary Medicine 2009, 9:38 http://www.biomedcentral.com/1471-2466/9/38
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ment. Additionally some Senior Emergency physicians
also were not supportive of one-on-one education.
Across the two intervention periods, a total of 185 staff
members in QLD were visited by CAPTION trained local
hospital project officers, with an average duration of 12.6
minutes. A mean of 12 staff members per hospital were
detailed, with the majority being to resident medical offic-
ers, followed by registrars and physicians. Sixteen group
education sessions were conducted, reaching a total of
208 staff members.
Comments received regarding the intervention included:
"Many doctors, particularly the junior doctors, appeared to be
appreciative of the session, and the information provided"
"Academic detailing; Thankful for input of pharmacist's time"
"Due to the busy nature of the ED, it is very difficult to capture
significant number of doctors to attend a group presentation"
"Found that detailing is very time consuming and would be eas-
ier to give a group session".
Evaluation of Project overall
In the final QLD CAPTION group wrap-up meeting, par-
ticipants from all nine hospitals undertook individual
hospital presentations, outlining their perceptions of the
benefits of the project. These benefits are grouped into the
impact on the hospital dynamic such as improved inter-
disciplinary working e.g. between pharmacist and doctor;
new roles for pharmacist in the ED; recognition of educa-
tional/academic role of the pharmacist and involvement
with the NPS and personal benefits. Participants
described personal benefits such as receiving academic
detailing training, improved communication skills to use
when aiming to influence prescribing, and the opportu-
nity to be involved in project work and resultant presenta-
tions personally rewarding. The drawback of participation
is the extra burden on already busy staff members, and
time commitments which may have made it difficult to
give the CAPTION project the attention warranted.
Positive and negative elements of participation were
reflected by participants:
"Essential Skills learned in influencing prescribing habits
through Academic Detailing."
"Really feels like we are making a difference in assisting
doctor's prescribing when seeing doctors calculating PSI
and prescribing based on Therapeutic Guideline recom-
mendations."
"It was found that most doctors were really appreciative of
someone taking the time to talk to them"
"Creating a pharmacy presence in the Emergency depart-
ment"
"Resource Materials and involvement with the NPS on a
nationwide basis"
"It was a good learning curve and I enjoyed the experi-
ence!!!"
"Time consuming"
"Try to track down doctors who were either busy or work-
ing on late shifts, and get them to sit down for 10 minutes
to have an academic detailing session!!!"
"Co-ordinating time, staff, health records, doing own
ward work AND being short of pharmacy staff"
The participants acknowledged the amount of extra work
that was required to participate in CAPTION, however
were appreciative of the personal rewards in participation
in a national multicentre project.
Where there was support at a District Manager level in the
CAPTION hospitals the participants found that the
project had wider acceptance. Other components reported
by CAPTION participants as impacting on the project
were the improved relationships between pharmacy and
medical staff and the training undertaken in academic
detailing. These were considered a major benefit of the
project.
Discussion
Intervention Evaluation
A number of methods have been described in the litera-
ture with respect to changing prescriber behaviour, with
varying levels of evidence about effectiveness. Interven-
tions that have shown some evidence for change include
audit and feedback [14] where response is usually better
when baseline concordance to recommendations is ini-
tially low. Group education sessions delivered in an inter-
active format have also been shown to change behavior,
but didactic education sessions are unlikely to have any
effect. [15] The CAPTION project used a suite of interven-
tions including audit, feedback and group presentations,
with the principle method of behaviour change being aca-
demic detailing. This technique, also known as educa-
tional visiting, which has been extensively reviewed [16-
18] and is commonly used in community practice in Aus-
tralia [3]. Until the CAPTION project however, the tech-
nique had not been formally implemented withinBMC Pulmonary Medicine 2009, 9:38 http://www.biomedcentral.com/1471-2466/9/38
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Australia's hospital system. Reasons for this are the inten-
sive training required (minimum two day workshop),
high turnover of staff and frequent rotation of medical
staff. It has been perceived in the past that this therefore
requires repetition of training and repetition of the actual
educational visit with new staff, which has not been con-
sidered to be an efficient or effective use of resources. Aca-
demic detailing to date has been evaluated only in
community practice, therefore data are still lacking on the
effectiveness of this educational technique in a hospital
setting.
In community practice in Australia, divisions of General
Practice employ facilitators to undertake educational vis-
iting (academic detailing) on behalf of the NPS, providing
visits of up to 40 minutes in duration. This duration
would be impractical in the hospital environment and
presented another barrier, and thus educational visits for
this CAPTION program were specifically tailored to last
approximately 10 minutes.
It was identified that there was some difficulty in making
appointments with Emergency Department doctors due
to the unpredictable nature of their workload. Group edu-
cation sessions in this setting were thus considered a more
suitable option. However academic detailing, when per-
formed in conjunction with other interventions proved to
be a useful educational strategy to change behaviour
within the Emergency Department in CAPTION.
A study from Germany [19] that evaluated the quality cir-
cle programmes to implement clinical guidelines in gen-
eral practice found that for doctors who participated in
the programme there was an increase in knowledge,
improved work relationships and was beneficial beyond
actual measured clinical care for patients. In the CAPTION
project the hospital coordinators reported that the benefit
of participation went beyond improving patient care and
also improved their inter-professional relationships and
their knowledge and was beneficial both personally and
to the hospital. An additional paper looking at decreasing
in-hospital mortality, reported on components that had
the most influence [20]. This demonstrated that leader-
ship by the hospital executive contributed to the success of
the strategy for change. Similarly where there was support
at a District Manager level in the CAPTION hospitals the
participants found that the project had wider acceptance.
Hospitals may not undertake such projects individually
due to the time commitments, including the preparation
of audit materials and preparation of education materials,
unless there is a designated project staff member such as a
DUE pharmacist. A national multicentre drug use evalua-
tion project such as CAPTION allows hospitals that would
otherwise not undertake such a project the opportunity to
participate. All materials were developed at a national
level resulting in a sharing of resources. Participation in a
multicentre project allows hospitals to benchmark their
own institution's data against state and national results. In
Australia we are fortunate to have the Therapeutic Guide-
lines, which assist in obtaining consensus about treatment
guidelines and facilitates multicentre projects. The QLD
arm of CAPTION resulted in other benefits to the individ-
ual participants and their hospitals. These benefits dem-
onstrated the additional value of participating in a
multicentre project of this type.
This paper reports the Queensland experience of partici-
pation in a national quality improvement initiative. This
program was conducted concurrently in New South
Wales, Victoria, South Australia and Tasmania, coordi-
nated nationally by the NPS. Similar experiences were
reported by the other states. The challenge in implement-
ing this type of program nationally is firstly obtaining
consensus. Not all physicians believe in the PSI, due to its
perceived complexity using 19 different variables, the
incorporation of arterial blood gases in the measurement
and the weighting due to age. Some hospitals believe that
the CURB [21] or CURB-65 [22] scores are easier to use.
The Therapeutic Guidelines: Antibiotic is well accepted in
Australia as a consensus document. Implementation in
other institutions or health systems may be more difficult
without a national coordinating body such as the NPS or
without firstly obtaining consensus for managing the
patient and choice of antibiotic.
It is however possible to apply the process discussed in
this paper to other health systems, using either the PSI or
another scoring system and conduct audit and feedback
along with an educational intervention incorporating
one-on-one education. Appropriate training in the educa-
tional techniques would be required. The additional chal-
lenges of implementing such a program such as time,
workload and training remain the same in any health sys-
tem.
Conclusion
Projects which aim to improve specific disease outcomes,
such as implementation of guidelines for the optimal
management of community acquired pneumonia, are
often perceived as difficult, of minimal benefit to the insti-
tution and not successful in achieving long lasting
changes. Participation in a multicentre DUE demon-
strated many benefits to the institutions and individuals
in addition to improvements in prescribing.
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